Exagen Depreciation & Amortization Growth & History (XGN)

Exagen's depreciation and amortization was $2.1M for fiscal 2025.

View full Exagen company overview

Exagen annual depreciation and amortization history

Exagen annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$2.1M$400,000+23.53%
20242024-12-31$1.7M−$500,000−22.73%
20232023-12-31$2.2M$600,000+37.50%
20222022-12-31$1.6M$700,000+77.78%
20212021-12-31$900,000$400,000+80.00%
20202020-12-31$500,000−$100,000−16.67%
20192019-12-31$600,000$00.00%
20182018-12-31$600,000

Exagen depreciation and amortization trends

Over the last five fiscal years, Exagen's depreciation and amortization increased from $500,000 to $2.1M, a change of $1.6M. The latest reported quarter, Q2 2026, shows $600,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Exagen source filings ↗

Community posts

It’s quiet here.

No posts about XGN yet. Start the conversation.

Write the first post